SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
OMCL

Omnicell, Inc. (NASDAQ:OMCL)

US · Delayed Price · Currency is USD
Healthcare · Medical - Healthcare Information Services
$32.51-$0.67 (-2.02%)
 
Market cap
$1.50B
Insider Score
Health Score
Analyst consensus
Listed since
Aug 7, 2001
Market Cap$1.50B-10.3%
Revenue (ttm)$1.24B+5.6%
Net Income$44.67M+124.2%
EPS$0.96+124.4%
Shares Out45.99M
PE Ratio33.35
Forward PE16.59
Dividendn/a
Ex-Dividend Daten/a
Volume564,519
Open$32.93
Previous Close$33.18
Day's Range$32.27 - $33.39
52-Week Range$31.75 - $55.00
Beta0.89
AnalystsBuy
Price Target$57.50(+76.87%)
Earnings DateFeb 4, 2027

About OMCL

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Address
4220 North Freeway, Fort Worth, TX, 76137, US
Market Cap
1.50 billion
Employees
3,450
Industrial Classification
Medical - Healthcare Information Services

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$1.04M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
1 Buy0 Hold0 SellAvg target $50.00 (+53.8%)

1 firm rating OMCL in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Strong
From OMCL’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-2.02%
5 Days
-6.79%
1 Month
-12.37%
6 Months
-26.80%
1 Year
-10.29%

$OMCL stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in OMCL holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by OMCL's directors and management

Net Shares Purchased by Insiders−20k−10k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

OMCL Estimated quarterly lobbying spending

Source: U.S. Senate LDA

OMCL Revenue by Segment or Geography

$307.85MTotal
Connected devices, software licenses, and other$146.11M47.46%
Technical services$67.78M22.02%
SaaS and Expert Services$67.02M21.77%
Consumables$26.94M8.75%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New OMCL patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to OMCL from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in OMCL

AVRYAvory Foundational ETF$436.00M
IJRiShares Core S&P Small-Cap ETF$91.15M
AFTYPacer CSOP FTSE China A50 ETF$58.58M
IWMiShares Russell 2000 ETF$39.62M
VTIVanguard Morningstar Total Stock Market ETF$39.54M
VBVanguard Morningstar Small-Cap ETF$35.54M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from OMCL’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
60
News & Sentiment
20% of score
55

News check: Mixed coverage with analytical pieces questioning valuation and inclusion in feature lists; no concrete catalyst news or earnings beats identified.

Recent Insider Activity

Buys
0
Sells
5
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

AVRYAvory Foundational ETF6.35%
EDOCGlobal X Telemedicine & Digital Health ETF2.22%
FDHTFIDELITY DIGITAL HEALTH ETF1.73%
XHEState Street SPDR S&P Health Care Equipment ETF1.58%
SILXETFMG Prime 2x Daily Junior Silver Miners ETF1.42%
HTECROBO Global Healthcare Technology and Innovation ETF1.16%
FDLSInspire Fidelis Multi Factor ETF1.11%
HEALGlobal X HealthTech ETF1.08%
CTRUARK Transparency ETF0.91%
PSCHInvesco S&P SmallCap Health Care ETF0.85%
PLCYEventShares U.S. Legislative Opportunities ETF0.83%
QQQSInvesco NASDAQ Future Gen 200 ETF0.57%

Weight is the stock’s share of each fund’s holdings.